Daily Archives: April 3, 2019

Flashpoint Gains Channel Momentum as Demand for Business Risk Intelligence Accelerates Worldwide

Partners Worldwide Turn to Flashpoint to Provide Customers with Intelligence to Support Unique Use Cases Across Multiple Sectors and Teams NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) — Flashpoint, the…

SurveyMonkey Completes Acquisition of Usabilla

Combined Companies Provide Access to a Truly Comprehensive Portfolio of Customer Experience Offerings SAN MATEO, Calif. and AMSTERDAM, The Netherlands, April 03, 2019 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK), a…

BNP Paribas Announces Investment in Forge and Launches Industry-First Investment Product focused on Pre-IPO Securities

NEW YORK and SAN FRANCISCO, April 03, 2019 (GLOBE NEWSWIRE) — BNP Paribas, a leading European provider of banking and financial services, announces an equity investment in Forge Global, Inc.…

VistaJet Launches Global Pet Travel Program as it Sees a 104% Increase in Animals Flying

VistaPet: the expert solution to make flying with pets as simple as possible NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) — VistaJet, the first and only global business aviation company,…

Thai Supreme Court Rules InfoQuest News Is Copyrighted Setting Norm For Media Industry In Thailand

The Supreme Court, the Intellectual Property and International Trade Division, ruled that articles, special reports and interview reports of InfoQuest are protected work under Copyright Act B.E. 2537 and that…

Report: Asian Economies Lag as Trade Tensions Drag on Growth

BANGKOK Trade tensions between China and the United States are putting a drag on economies in the region, with growth likely to continue to slow in the coming two years,…

Ukrainian Diaspora Voters Show Starkly Different Political Preferences for Kyiv

LONDON Ukrainians who live abroad strongly prefer sitting President Petro Poroshenko to other candidates in last weekend’s firstround presidential election, contradicting the choice of voters who reside within the eastern…

Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pre-clinical in vivo models of lung cancer

Data presented at AACR Annual Meeting 2019 In vivo study conducted alone or in collaboration with The University of Texas MD Anderson Cancer Center demonstrated: NBTXR3 in combination with a…